Does TOFACITINIB Cause Product use issue? 4,817 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 4,817 reports of Product use issue have been filed in association with TOFACITINIB (XELJANZ XR). This represents 3.1% of all adverse event reports for TOFACITINIB.
4,817
Reports of Product use issue with TOFACITINIB
3.1%
of all TOFACITINIB reports
809
Deaths
1,526
Hospitalizations
How Dangerous Is Product use issue From TOFACITINIB?
Of the 4,817 reports, 809 (16.8%) resulted in death, 1,526 (31.7%) required hospitalization, and 1,111 (23.1%) were considered life-threatening.
Is Product use issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TOFACITINIB. However, 4,817 reports have been filed with the FAERS database.
What Other Side Effects Does TOFACITINIB Cause?
Drug ineffective (30,382)
Pain (21,659)
Condition aggravated (16,925)
Arthralgia (15,640)
Fatigue (13,551)
Rheumatoid arthritis (12,277)
Off label use (11,736)
Headache (11,061)
Joint swelling (10,686)
Malaise (9,040)
What Other Drugs Cause Product use issue?
INFLIXIMAB (12,752)
DUPILUMAB (10,575)
POLYETHYLENE GLYCOL 3350 (9,432)
METHOTREXATE (8,185)
DICLOFENAC (8,009)
RITUXIMAB (6,948)
ADALIMUMAB (6,379)
ETANERCEPT (6,062)
TOCILIZUMAB (5,944)
ABATACEPT (5,915)
Which TOFACITINIB Alternatives Have Lower Product use issue Risk?
TOFACITINIB vs TOFERSEN
TOFACITINIB vs TOLNAFTATE
TOFACITINIB vs TOLODODEKIN ALFA
TOFACITINIB vs TOLTERODINE
TOFACITINIB vs TOLVAPTAN